Helena Hansen et al., "Whiteout: How Racial Capitalism Changed the Color of Opioids in America" (U California Press, 2023)

Helena Hansen et al., "Whiteout: How Racial C...

Up next

Martin Heidegger, "Being and Time: An Annotated Translation" (Yale UP, 2026)

A full century ago, a young and relatively unknown philosophy instructor in a small town in Germany would publish a book that would be swiftly picked up and radically reshape the intellectual landscape around it. Everything published before could now be reread in a new light, whi ...  Show more

Michelle Jackson, "The Division of Rationalized Labor" (Harvard UP, 2025)

How have jobs changed in the last 150 years? In The Division of Rationalized Labor (Harvard UP, 2025) Michelle Jackson, an Associate Professor in the Department of Sociology at Stanford University examines the original theories about the division of labour and explains why many ...  Show more

Recommended Episodes

Racism, Class, and the Opioid Crisis
The Dig

Featuring Helena Hansen, Jules Netherland, and David Herzberg on how American capitalism and its illusions of whiteness both created the opioid crisis and shaped the response to it. We are discussing their book Whiteout: How Racial Capitalism Changed the Color of Opioids in Ameri ...  Show more

589. Why Has the Opioid Crisis Lasted So Long?
Freakonomics Radio

Most epidemics flare up, do their damage, and fade away. This one has been raging for almost 30 years. To find out why, it’s time to ask some uncomfortable questions. (Part one of a two-par ...

  Show more

Episode 176: Antiracism in Medicine Series – Episode 8 – Towards Justice and Race Conscious Medicine
The Clinical Problem Solvers

“There’s nothing new under the sun, but there are new suns” – Octavia E. Butler Summary: We invite social justice champion and acclaimed scholar of race, gender, and the law, Dorothy E. Roberts, JD, to discuss the history of race-based medicine and the movement for he ...  Show more

590. Can $55 Billion End the Opioid Epidemic?
Freakonomics Radio

Thanks to legal settlements with drug makers and distributors, states have plenty of money to boost prevention and treatment. Will it work? (Part two of a two-part series.)

 

< ...  Show more